Advertisement

Vanin-1 as a novel biomarker for chronic obstructive pulmonary disease

  • Author Footnotes
    1 The authors share the equal work.
    Xue Zhang
    Footnotes
    1 The authors share the equal work.
    Affiliations
    Department of Respiratory and Intensive Medicine, Daqing Oilfield General Hospital, 9 Zhongkang Street, Daqing 163001, China
    Search for articles by this author
  • Author Footnotes
    1 The authors share the equal work.
    Wenchao Cong
    Footnotes
    1 The authors share the equal work.
    Affiliations
    Department of Respiratory and Intensive Medicine, Daqing Oilfield General Hospital, 9 Zhongkang Street, Daqing 163001, China
    Search for articles by this author
  • Aiping Lu
    Correspondence
    Corresponding author.
    Affiliations
    Department of Respiratory Medicine, Daqing People's Hospital, 241 Jianshe Road, Daqing 163000, China
    Search for articles by this author
  • Author Footnotes
    1 The authors share the equal work.

      Abstract

      Background

      The function of vascular non-inflammatory molecule 1 (Vanin-1), an enzyme essential for vitamin B5 synthesis, has not been studied yet in chronic obstructive pulmonary disease (COPD).

      Objectives

      In this study, we aimed to evaluate the expression of Vanin-1 in sera and lung tissues of COPD, and infer its possible roles in COPD.

      Methods

      We collected blood and lung tissue specimens from 99 COPD patients and 62 non-COPD subjects. Enzyme-linked immunosorbent assay was used to determine levels of Vanin-1, pantothenic acid, interleukin-6 (IL-6), tumor necrotic factor α (TNFα), and reactive oxygen species (ROS). The receiver operating characteristics (ROC) curve was used for analysis of the diagnostic value of Vanin-1 in COPD patients. Pearson's correlation assay was used to determine the correlation between Vanin-1 and levels of inflammatory cytokines and ROS.

      Results

      Vanin-1 expression was significantly higher in the sera and lung tissues of COPD patients compared to non-COPD subjects. ROC analysis showed that the area under the curve (AUC) was greater than 0.5 for both sera (AUC = 0.7342) and lung tissues (AUC = 0.9061). Pantothenic acid was also upregulated in COPD patients. IL-6, TNFα and ROS showed strong positive correlations to Vanin-1 levels in sera.

      Conclusion

      Vanin-1 upregulation in sera and lung tissue is a potentially valuable biomarker for COPD. Vanin-1 showed positive correlations to levels of pro-inflammatory cytokines and ROS. Together, our results support the further development of Vanin-1 as a new target for the diagnosis or treatment of COPD.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart & Lung: The Journal of Cardiopulmonary and Acute Care
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Alqahtani JS
        • Oyelade T
        • Aldhahir AM
        • Alghamdi SM
        • Almehmadi M
        • Alqahtani AS
        • et al.
        Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis.
        PLoS One. 2020; 15e0233147
        • Sullivan J
        • Pravosud V
        • Mannino DM
        • Siegel K
        • Choate R
        • Sullivan T.
        National and state estimates of COPD morbidity and mortality—United States, 2014-2015.
        Chronic Obstr Pulm Dis: J COPD Found. 2018; 5: 324
        • Nathell L
        • Nathell M
        • Malmberg P
        • Larsson K.
        COPD diagnosis related to different guidelines and spirometry techniques.
        Respir Res. 2007; 8: 1-7
        • Naquet P
        • Pitari G
        • Dupre S
        • Galland F.
        Role of the Vnn1 pantetheinase in tissue tolerance to stress.
        Biochem Soc Trans. 2014; 42: 1094-1100
        • Kavian N
        • Mehlal S
        • Marut W
        • Servettaz A
        • Giessner C
        • Bourges C
        • et al.
        Imbalance of the Vanin-1 Pathway in systemic sclerosis.
        J Immunol. 2016; 197: 3326-3335
        • Lu H
        • Zhang A
        • Wen D
        • Du J
        • Sun J
        • Qiao L
        • et al.
        Plasma Vanin-1 as a novel biomarker of sepsis for trauma patients: a prospective multicenter cohort study.
        Infect Dis Ther. 2021; 10: 739-751
        • Zhang B
        • Lo C
        • Shen L
        • Sood R
        • Jones C
        • Cusmano-Ozog K
        • et al.
        The role of vanin-1 and oxidative stress–related pathways in distinguishing acute and chronic pediatric ITP.
        Blood, The Journal of the American Society of Hematology. 2011; 117: 4569-4579
        • Bartucci R
        • Salvati A
        • Olinga P
        • Boersma YL.
        Vanin 1: its physiological function and role in diseases.
        Int J Mol Sci. 2019; 20: 3891
        • Ho T
        • Cusack RP
        • Chaudhary N
        • Satia I
        • Kurmi OP.
        Under- and over-diagnosis of COPD: a global perspective.
        Breathe (Sheff). 2019; 15: 24-35
        • Singh D
        • Fox SM
        • Tal-Singer R
        • Plumb J
        • Bates S
        • Broad P
        • et al.
        Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers.
        Thorax. 2011; 66: 489-495
        • Mathioudakis AG
        • Bikov A
        • Foden P
        • Lahousse L
        • Brusselle G
        • Singh D
        • et al.
        Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD.
        Eur Respir J. 2020; 55
        • Yip KT
        • Das PK
        • Suria D
        • Lim CR
        • Ng GH
        Liew CC. A case-controlled validation study of a blood-based seven-gene biomarker panel for colorectal cancer in Malaysia.
        J Exp Clin Cancer Res. 2010; 29: 128
        • Marshall KW
        • Mohr S
        • Khettabi FE
        • Nossova N
        • Chao S
        • Bao W
        • et al.
        A blood-based biomarker panel for stratifying current risk for colorectal cancer.
        Int J Cancer. 2010; 126: 1177-1186
        • Izzi V
        • Lakkala J
        • Devarajan R
        • Savolainen ER
        • Koistinen P
        • Heljasvaara R
        • et al.
        Vanin 1 (VNN1) levels predict poor outcome in acute myeloid leukemia.
        Am J Hematol. 2018; 93: E4-E7
        • Xiao C
        • Biagini Myers JM
        • Ji H
        • Metz K
        • Martin LJ
        • Lindsey M
        • et al.
        Vanin-1 expression and methylation discriminate pediatric asthma corticosteroid treatment response.
        J Allergy Clin Immunol. 2015; 136 (e3): 923-931
        • Washino S
        • Hosohata K
        • Oshima M
        • Okochi T
        • Konishi T
        • Nakamura Y
        • et al.
        A Novel Biomarker for Acute Kidney Injury, Vanin-1, for Obstructive Nephropathy: A Prospective Cohort Pilot Study.
        Int J Mol Sci. 2019; : 20
        • Hosohata K
        • Matsuoka H
        • Iwanaga K
        • Kumagai E.
        Urinary vanin-1 associated with chronic kidney disease in hypertensive patients: A pilot study.
        J Clin Hypertens. 2020; 22: 1458-1465
        • Hosohata K
        • Ando H
        • Fujiwara Y
        • Fujimura A.
        Vanin-1: a potential biomarker for nephrotoxicant-induced renal injury.
        Toxicology. 2011; 290: 82-88
        • Berruyer C
        • Pouyet L
        • Millet V
        • Martin FM
        • LeGoffic A
        • Canonici A
        • et al.
        Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor γ activity.
        J Exp Med. 2006; 203: 2817-2827
        • Kirkham PA
        • Barnes PJ.
        Oxidative stress in COPD.
        Chest. 2013; 144: 266-273
        • Vogelmeier C
        • Buhl R
        • Burghuber O
        • Criee C
        • Ewig S
        • Godnic-Cvar J
        • et al.
        Guideline for the diagnosis and treatment of COPD patients-issued by the German respiratory society and the German Atemwegsliga in cooperation with the Austrian Society of Pneumology.
        Pneumologie. 2018; 72: 253-308
        • Kim T-O
        • Shin H-J
        • Kim Y-I
        • Rhee C-K
        • Lee W-Y
        • Lim S-Y
        • et al.
        Adherence to the GOLD guideline in COPD management of South Korea: findings from KOCOSS study 2011–2018.
        Chonnam Med J. 2019; 55: 47-53